Park Medi World Ltd. Schedules September Results Review

Park Medi World Ltd. has scheduled a Board of Directors meeting for November 9, 2026, to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026, following reported June-quarter revenue growth of 19%.

When will Park Medi World review its September 2026 results?

Park Medi World will hold its board meeting on November 9, 2026, to consider and approve its standalone and consolidated unaudited financial results for the quarter and six months ended September 30, 2026. The disclosure was made through a company filing submitted to BSE.

The meeting is relevant because it will provide the company’s next formal update on financial performance after the June 2026 quarter. The filing describes the agenda as consideration and approval of the results; it does not provide the September-quarter financial figures in advance.

The planned review covers both standalone and consolidated statements. Standalone results reflect the company’s own operations, while consolidated results include the financial position of the parent and entities included under applicable accounting requirements.

What happened at Park Medi World's previous results meeting?

Park Medi World’s board approved standalone and consolidated unaudited results for the quarter ended June 30, 2026, at its meeting on August 3, 2026. The company said its audit committee reviewed the statements before the board’s approval, in line with Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

The company’s statutory auditors conducted a limited review of the June-quarter standalone and consolidated financial results and issued an unmodified opinion, according to the notes accompanying the results. An unmodified opinion means the auditors did not modify their conclusion on the reviewed financial statements.

The company had previously informed exchanges that the August 3 meeting would consider the June-quarter results. After the meeting, it disclosed that the board had approved the unaudited financial results and later submitted an investor presentation for the quarter.

What did Park Medi World report for the June 2026 quarter?

Park Medi World’s investor presentation showed consolidated revenue excluding other income of 4,757 for the quarter ended June 30, 2026, compared with 3,988 in the corresponding earlier period, representing 19% growth. The presentation did not state the unit alongside the extracted revenue table, so the figure is presented as reported.

The same table showed revenue of 4,604 for the preceding comparison period, indicating 3% sequential growth. Cost of material consumed and services rendered was reported at 763, compared with 700 in the year-earlier period and 796 in the prior comparison period. The reported changes were 9% year-on-year growth and a 4% sequential decline, respectively.

These figures provide the immediate financial context for the September-quarter board meeting. However, they do not establish the September-quarter outcome, as the company has not disclosed the financial statements that the board is scheduled to consider on November 9.

Why does the September results meeting matter to investors?

The September results will cover both a three-month period and the first half of the financial year ending March 2027. That will allow investors to compare the company’s reported June-quarter revenue trend with its performance in the following quarter, once the board approves and the company releases the results.

The meeting is also part of the disclosure process prescribed for listed companies. Park Medi World’s earlier filings cited Regulations 29, 30 and 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, for advance meeting intimation, material disclosure and financial-results reporting.

A brokerage recommendation was also referenced in the available filings. Choice Institutional Equities had issued a buy call on Park Medi World with a target price of ₹350. The source does not provide the valuation assumptions, date of the recommendation, current market price or subsequent price movement, so those details cannot be assessed from this disclosure.

How have Park Medi World's financial disclosures been reviewed?

Park Medi World stated that its June 2026 standalone and consolidated results were reviewed by the audit committee on August 3 and then approved by the board on the same day. The company said the statutory auditors issued unmodified limited-review opinions on those statements.

For the quarter and nine months ended December 31, 2025, the company reported a similar process. Its board approved the unaudited standalone and consolidated results on January 28, 2026, after audit committee review. The board meeting commenced at 9:00 a.m. and concluded at 11:48 a.m., according to the filing.

The notes also said that comparative standalone figures for the quarter and nine months ended December 31, 2024 had been approved by the board but had not been reviewed by the statutory auditors. This disclosure relates to the historical comparative figures and is separate from the June 2026 limited review.

Conclusion

Park Medi World’s November 9 meeting is the scheduled decision point for unaudited standalone and consolidated results for the September 2026 quarter and first half. The latest financial context in the available material is the June-quarter presentation, which reported revenue excluding other income of 4,757 and year-on-year growth of 19%.

Investors will next watch for the board-approved September-quarter statements, the accompanying limited-review report and any investor presentation or operational commentary released after the meeting. The current filing does not disclose September-quarter revenue, profit, margins or any revised target or operating plan.